N-(5-Guanidino-1-((4-nitrophenyl)amino)-1-oxopentan-2-yl)benzamide hydrochloride(CAS: 911-77-3)

This compound falls under the classification and labelling requirements of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes specific health and environmental hazards. It is also subject to the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations in the European Union. In the United States, it is regulated by the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA).

Several alternatives can be used, including analogs such as N-(5-amino-1-((4-nitrophenyl)amino)-1-oxopentan-2-yl)benzamide and related guanidine compounds. Isomers and other reagents like 4-nitroaniline derivatives or other amide compounds can serve as substitute solutions in the synthesis process.

The research trend for this compound indicates increasing interest in its application in pharmaceutical and biotech industries, due to its potential in developing new therapeutic agents. Market demand is likely to grow as ongoing research reveals its biological activities and potential in various fields such as antiviral and anticancer treatments.

Waste containing this compound should be collected in appropriate containers and disposed of through incineration or professional waste disposal services. Environmental protection guidelines should be followed to minimize environmental impact, and proper personal protective equipment should be used during handling to ensure safety. Regulatory authorities should be consulted for specific disposal requirements.